Haoxi Health Technology Limited
HAO
$0.98
-$0.03-3.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.80M | 40.89M | 48.97M | 48.75M | 48.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.80M | 40.89M | 48.97M | 48.75M | 48.52M |
| Cost of Revenue | 31.88M | 39.41M | 46.94M | 46.36M | 45.77M |
| Gross Profit | 927.80K | 1.48M | 2.03M | 2.39M | 2.75M |
| SG&A Expenses | 2.85M | 1.99M | 1.14M | 1.05M | 953.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.80M | 41.50M | 48.20M | 47.50M | 46.80M |
| Operating Income | -2.00M | -614.30K | 771.40K | 1.24M | 1.72M |
| Income Before Tax | 4.15M | 2.54M | 937.00K | 1.34M | 1.74M |
| Income Tax Expenses | 270.80K | 454.50K | 638.20K | 540.90K | 443.60K |
| Earnings from Continuing Operations | 3.88 | 2.09 | 0.30 | 0.80 | 1.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.88M | 2.09M | 298.80K | 795.20K | 1.29M |
| EBIT | -2.00M | -614.30K | 771.40K | 1.24M | 1.72M |
| EBITDA | -1.71M | -459.40K | 787.40K | 1.26M | 1.74M |
| EPS Basic | 1.31 | 0.80 | 0.29 | 0.68 | 1.06 |
| Normalized Basic EPS | 0.91 | 0.69 | 0.46 | 0.67 | 0.88 |
| EPS Diluted | 1.01 | 0.65 | 0.29 | 0.68 | 1.06 |
| Normalized Diluted EPS | 0.87 | 0.67 | 0.46 | 0.67 | 0.88 |
| Average Basic Shares Outstanding | 9.34M | 7.75M | 6.17M | 5.53M | 4.90M |
| Average Diluted Shares Outstanding | 9.59M | 7.88M | 6.17M | 5.53M | 4.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |